Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack has significant risks: 1 interaction(s) to avoid and 1 critical warning(s). Review carefully before proceeding.
1 combination(s) marked "avoid": Dianabol + LGD-4033. Review these interactions carefully.
Elevated gonads load from Dianabol, LGD-4033. Monitor this organ system closely.
Elevated liver load from Dianabol, LGD-4033. Monitor this organ system closely.

Cumulative Organ Load

Gonads
elevated
Liver
elevated
Heart
moderate

Shared Safety Flags

2x 2 androgenic compounds (Dianabol, LGD-4033). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds raise blood pressure (Dianabol, LGD-4033). Monitor BP daily and consider cardiovascular support.
2x 2 compounds share the carcinogenic-risk safety flag (Dianabol, LGD-4033). Monitor accordingly.
2x 2 estrogenic compounds (Dianabol, LGD-4033). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 hepatotoxic compounds (Dianabol, LGD-4033). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (Dianabol, LGD-4033). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Dianabol, LGD-4033). Get lipid panel mid-cycle — consider adding lipid support.
!
Dianabol + LGD-4033
Avoid

Both Dianabol and LGD-4033 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Mechanism-based 64% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.